<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04417608</url>
  </required_header>
  <id_info>
    <org_study_id>N202003147</org_study_id>
    <nct_id>NCT04417608</nct_id>
  </id_info>
  <brief_title>Looking for Minimum Dose to Induce Sympathectomy in Infraclavicular Brachial Plexus Block</brief_title>
  <official_title>Looking for Minimum Dose to Induce Sympathectomy in Infraclavicular Brachial Plexus Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Medical University WanFang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Medical University WanFang Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For patients who undergoing hemodialysis, it is important to have good AV fistula. One third
      of AV fistula usually fail during early stage. It is helpful to use nerve block to dilate the
      blood vessels and enhance the prognosis. But 0.2% Ropivacaine usually cause muscle weakness
      in present studies. The investigators hope to find the lowest concentration to provide
      sympathectomy without muscle weakness. Because the patients with hemodialysis usually have
      multiple co-morbidity, thus we choose patients with forearm fracture at the first place. With
      this result, the investigators can design further study for patients with hemodialysis. The
      investigators prefer proximal approach because brachial plexus run together in the
      cosctoclavicular space and show lower incidence of incomplete work.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 4, 2020</start_date>
  <completion_date type="Anticipated">July 4, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 4, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of diameter of basilic vein and brachial artery</measure>
    <time_frame>Change from baseline diameter(pre-nerve block) at 45min</time_frame>
    <description>Use ultrasound to measure the difference of diameter at different time point.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of diameter of basilic vein and brachial artery</measure>
    <time_frame>Change from baseline diameter(pre-nerve block) at 24hour</time_frame>
    <description>Use ultrasound to measure the difference of diameter at different time point.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of diameter of basilic vein and brachial artery</measure>
    <time_frame>Change from baseline diameter(pre-nerve block) at 48hour</time_frame>
    <description>Use ultrasound to measure the difference of diameter at different time point.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensory block of upper limb</measure>
    <time_frame>45min post nerve block</time_frame>
    <description>A validated 3-point scale was used: 0 = no block (patient has normal sensation), 1 = patient can feel cold, but the sensation is reduced compared with the unblocked side, and 2 = complete anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory block of upper limb</measure>
    <time_frame>24hour post nerve block</time_frame>
    <description>A validated 3-point scale was used: 0 = no block (patient has normal sensation), 1 = patient can feel cold, but the sensation is reduced compared with the unblocked side, and 2 = complete anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor block of upper limb</measure>
    <time_frame>45min post nerve block</time_frame>
    <description>A validated 3-point scale was used: 0 = no block (patient has normal power), 1 = patient can feel weakness with the unblocked side, and 2 = complete anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor block of upper limb</measure>
    <time_frame>24hour post nerve block</time_frame>
    <description>A validated 3-point scale was used: 0 = no block (patient has normal power), 1 = patient can feel weakness with the unblocked side, and 2 = complete anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor block of upper limb</measure>
    <time_frame>48hour post nerve block</time_frame>
    <description>A validated 3-point scale was used: 0 = no block (patient has normal power), 1 = patient can feel weakness with the unblocked side, and 2 = complete anesthesia.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Finding the Minimum Dose to Induce Sympathectomy in Infraclavicular</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Infraclavicular brachial plexus block</intervention_name>
    <description>Ultrasound-guided infraclavicular brachial plexus block</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are scheduled for upper limb surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 20-80 y/o, BW: 40-90 kilograms，ASA class I-III，No pre-existing
             neuropathy，Scheduled for upper limb surgery.

        Exclusion Criteria:

          1. Pre-existing neuropathy (ex: polyneuropathy)

          2. History of allergy to xylocaine、ropivacaine、epinephrine

          3. Emergent surgery

          4. Coagulopathy

          5. Patient who can not express themselves
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 31, 2020</study_first_submitted>
  <study_first_submitted_qc>June 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Medical University WanFang Hospital</investigator_affiliation>
    <investigator_full_name>anchihhsu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Signs and Symptoms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

